As the world moves away from chemical pesticides, MustGrow is at the forefront of ethical (and profitable) investment.
The MustGrow Biologics Corporation has emerged as a company of great interest for one leading figure in the investment field, who saw the work being done by this agriculture biotech company and realised it was an opportunity that needed to be grabbed while it was hot, and it could be getting hotter.
As listed on the Canadian stock exchange, there is great potential seen in the company’s potential future and prospects, according to impact investment specialist Barry Palte.
The stock price has gone from $0.40 (Canadian) at the time of Palte’s initial investment, to having recently surpassed $2.20 a share, representing a 600% increase in the space of four months.
At the forefront of ethical investments – and having shown that ethical investments aren’t just the right thing to do, but that they bring serious financial dividends – Palte says that this company is making the most of that region’s bountiful, renewable and natural resources, by making an organic pesticide that’s truly cutting the mustard.
Citing the recent litigation against pest control company RoundUp, Palte highlighted how certain chemistries are being banned or deregistered across the globe amid a wider consumer base demanding food that is healthy, natural and safe.
Palte sees in MustGrow a company whose primary focus is on disrupting the US$65 billion global pesticide market with a product which meets the needs of primary producers, by being an effective and safe protection for their crops.
“What’s increasingly happening is that pest control solutions are chemically-based in many jurisdictions, that chemical formula is outright banned. This means that things that have been used to control pests around crops is globally a big issue around food,” he said
Having been invited to join MustGrow as a strategic investor and global advisor, Palte has been assisting them to work through their overall game plan, their strategy, its implementation, and then to shift the Canadian company’s focus from the specifics of the US-Canada market to a broader global market, “as quickly as possible.”
He sees in MustGrow a company whose primary focus is on disrupting the US$65 billion global pesticide market with a product which meets the needs of primary producers, by being an effective and safe protection for their crops.
MustGrow’s headquarters put it in close proximity to the Canadian province of Saskatchewan, produces 30% of the world’s mustard crop. Thanks to both its agriculture economy and the evolving uses for its primary crop, it’s steadily becoming known as the ‘Silicon Valley of AgTech’.
Focused on providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops (such as organic fruit & vegetables), the company holds the patent on the mustard-derived technology behind the creation of a natural biopesticide that acts as a pre-plant treatment for soil-borne pests and diseases.
Palte saw his own affiliation with MustGrow as being a sensible forward step for his investment firm, who make it their business to be on the forefront of those companies and investment opportunities to bring about a greater social or environmental good.
“We’re working with what we’re calling ultra-high positive impact technologies and companies to get them commercialised and in the market.”
The company has shifted its product focus from its initial granular formula, to a more effective and efficient liquid formulation, which they believe has substantial potential for multiple applications in several markets, in turn aggressively increasing their IP. Theirs is a formula with proven success against dreaded pests and diseases, including Plasmodium (club root), Rhizoctonia Fungus, Phytophthora Root Rot, and Botrytis (grey mould), to name a few.
There’s little not to like about the product: between governments around the world banning the use of chemical pesticides, to the intrinsic value of an ethical investment of this kind into a company making a product which works outside such restrictions with positive results.
“When we came on the scene, their existing product (the granular formation), they’ve since developed the liquid form, which is much more easily applied. That product was going through the EPA process and it had then not been approved.
“We came on board and said ‘Let’s work through the other applications,’ because there are many, many applications for this technology.”
He saw how the MustGrow technology could be applied to not only bananas, but potatoes as well as scores of other fruits, vegetables, grains and pulses, and save the global industry millions in lost revenue. The product has demonstrated 100% effectiveness, in laboratory trials in Colombia, against Panama Disease which is responsible for killing up to 30% of the Global banana crop and against which there is no current solution.
There is, according to Palte, little not to like about the product: between governments around the world banning the use of chemical pesticides, to the intrinsic value of an ethical investment of this kind into a company making a product which works outside such restrictions with positive results.
“I saw the company and thought it was crazily undervalued for what it was currently doing,” he said.